A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors

JAMA

Volumn 308, Issue 16, 2012, Pages 1629-1631

  Kratz, Johannes R ^a   Van Den Eeden, Stephen K ^b   He, Jianxing ^c   Jablons, David M ^a   Mann, Michael J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ASSAY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LETTER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RNA EXTRACTION; SURVIVAL RATE; TUMOR VOLUME;

EID: 84867702109     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.13551     Document Type: Letter

References (6)

1. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review [published correction appears in JAMA. 2012;308(13):1324]. JAMA. 2012;307(22):2418-2429.
2. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260-271.
3. Kratz JR, He J, Van Den Eeden SK, et al. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012;379(9818):823- 832.
4. National Comprehensive Cancer Network. NCCN Clinical practice guidelines on non-small cell lung cancer. http://www.nccn.org/professionals/physician-gls/ f-guidelines.asp. Accessibility verified September 28, 2012.
5. Pignon JP, Tribodet H, Scagliotti GV, et al; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26(21):3552-3559.
6. Zhu CQ, Ding K, Strumpf D, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol. 2010;28(29):4417-4424.